Navigation Links
Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn

Class-action lawsuits can significantly slow or halt science's ability to establish links between neurological illness and environmental //factors produced by industry, a team of scientists and lawyers warns in the journal Neurology.

The authors caution that litigation's effects could seriously impair efforts to identify compounds that contribute to a wide variety of diseases, including Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS). They provide suggestions for policy changes to help shield scientists and their research. Recommendations include enhancing privacy protections for patient data obtained in research projects and eliminating financial conflicts-of-interest for scientists actively involved in research related to the litigation.

The lead author, Brad A. Racette, M.D., associate professor of neurology at Washington University School of Medicine in St. Louis, writes from personal experience: His studies tentatively linking welding to increased risk of Parkinson's disease resulted in a torrent of subpoenas for research data. Responding to them slows or stops his follow-up research.

"Participation in the legal system can be a huge burden on a researcher's schedule," Racette says. "There comes a point where a scientist needs the right to be able to say, testifying in court is not what I'm supposed to be doing, I'm supposed to be studying disease."

In addition to the scheduling challenges, parties involved in lawsuits often demand extensive disclosure of scientific data that disrupts research and threatens the privacy of patients and research volunteers. The two lawyers who are coauthors on the Neurology article, Ann Bradley and Carrie A. Wrisberg, worked with Racette to defend his data from unreasonable disclosure requests.

"I'm fortunate in that I work for a university that was willing to defend the value and privacy of our research data," Racette says. "Other scientists a ren't so lucky."

The federal Health Insurance Portability and Accountability Act (HIPAA) prohibits release of data that can be used to identify patients, Racette notes. However, in many instances the extensive volume and particularity of data demanded by lawyers may still permit research subjects to be identified.

"To protect patient privacy and the value of our research data, we need specific, across-the-board restrictions on information that can be released in the courtroom," he says. "For example, Illinois has a law that designates medical research data as protected. That should be a model for other states."

The authors note that the substantial financial interests at stake in lawsuits often leads to biased research by well-paid expert witnesses. They cite the example of a Texas doctor found to be overdiagnosing a disease known as silicosis. The doctor had a financial interest in the number of patients diagnosed.

Peer review is of course a part of the regular scientific process, Racette notes, but a knowledgeable expert can design a study with a predetermined goal of discrediting earlier studies that linked a suspected toxin to a disease.

Industries on the defensive have also attempted to impugn the credibility of researchers. As an example, the authors cite the case of Herbert Needleman, M.D., professor of psychiatry and pediatrics at the University of Pittsburgh and the first scientist to link lead exposure to low IQ levels in children. The lead industry attacked Needleman's integrity, alleging academic fraud and triggering investigations by the Federal Scientific Integrity Board and his university. The investigations failed to find any evidence of academic fraud, and Needleman's results were later replicated, leading to beneficial changes such as the removal of lead from gasoline.

"It's really quite an eye-opener," Racette says. "Herb Needleman had to endure great personal and financial hardships , including the prospect of career loss and $85,000 in personal legal fees, all because he dared to study something produced by a powerful industry that might be harmful to people."

Racette admits that the difficulties litigation has imposed on his research has, at times, made the thought of switching his focus to a different area tempting. But he says he's much too stubborn to ever seriously consider such a step.

"To cure or prevent intractable disorders like the one I focus on, Parkinson's disease, scientists need to be free to investigate many different potential causes, including environmental factors produced by industry," he says. "We hope to get a national dialogue going about how we can create an environment where scientists are as free as possible to do good, unbiased research."

Racette's frequent collaborator Joel S. Perlmutter, M.D., professor of neurology, radiology and physical therapy and associate professor of neurobiology, is senior author of the paper.

Source-Newswise
'"/>




Related medicine news :

1. Is Stem Cell Research Likely to Be Stymied?
2. Indian Nationals with Foreign Medical Degrees can now practice in India
3. Meditation Works Medically
4. Sleep Disorders Could Indicate Other Medical Problems
5. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
6. Hypnosis Found To Reduce Stress In Children During Medical Procedures
7. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
8. Ayurvedic Therapies Cashing In On Medical Tourism
9. Prevention And Timely Medical Care Can Help With Bug Bites
10. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
11. Grant of $7 million for Orissa Medical College from Japan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology: